Researcher
Dirk Hose
- Keywords:Medicine
- Disciplines:Other basic sciences not elsewhere classified
Affiliations
- Hematology (Research group)
Member
From22 Mar 2021 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Mar 2020 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Mar 2020 → Today
Publications
1 - 10 of 108
- Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma(2023)
Authors: Rong Fan, Hatice Satilmis, Niels Vandewalle, Emma Verheye, Philip Vlummens, Anke Maes, Catharina Muylaert, Elke De Bruyne, Eline Menu, Holly Evans, et al.
- Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma(2023)
Authors: Elias K Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, et al.
- Systematic literature review of health economic models developed for multiple myeloma to support future analyses(2023)
Authors: Mimi Choon-Quinones, Tamás Zelei, Bertalan Németh, Manna Tóth, Xiao Yang Jia, Mike Barnett, Paul Keown, Brian Durie, Jean-Luc Harousseau, Dirk Hose, et al.
Pages: 110-119 - The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance(2022)
Authors: Sara Ovejero, Elena Viziteu, Laure Dutrieux, Julie Devin, Yea-Lih Lin, Elina Alaterre, Michel Jourdan, Jihane Basbous, Guilhem Requirand, Nicolas Robert, et al.
- Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach(2022)
Authors: Philip Vlummens, Stefaan Verhulst, Kim De Veirman, Anke Maes, Eline Menu, Jerome Moreaux, Elke De Bruyne, Dirk Hose, Karin Vanderkerken, Ken Maes
- Resemblance-Ranking Peptide Library to Screen for Binders to Antibodies on a Peptidomic Scale(2022)
Authors: Felix Jenne, Sergey Biniaminov, Nathalie Biniaminov, Philipp Marquardt, Clemens von Bojničić-Kninski, Roman Popov, Anja Seckinger, Dirk Hose, Alexander Nesterov-Mueller
- Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis(2022)
Authors: Inge Oudaert, Hatice Satilmis, Philip Vlummens, Wouter De Brouwer, Anke Maes, Dirk Hose, Elke De Bruyne, Bart Ghesquière, Karin Vanderkerken, Kim De Veirman, et al.
Pages: 45 - MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma(2022)
Authors: Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Martina Emde-Rajaratnam, Hans J Salwender, Uta Bertsch, et al.
Pages: 515-520 - Beyond medicines' barriers(2022)
Authors: Mimi Choon-Quinones, Tamás Zelei, Mike Barnett, Paul Keown, Brian Durie, Zoltán Kaló, Tímea Almási, Jean-Luc Harousseau, Dirk Hose
Pages: 1167-1175 - JunB is a key regulator of multiple myeloma bone marrow angiogenesis(2021)
Authors: Fengjuan Fan, Stefano Malvestiti, Sonia Vallet, Judith Lind, Jose Manuel Garcia-Manteiga, Eugenio Morelli, Qinyue Jiang, Anja Seckinger, Dirk Hose, Hartmut Goldschmidt, et al.
Pages: 3509-3525